Fighting diseases of global impact
Our unique research expertise makes us the only institute of its kind in Australia and only one of a handful in the world. We seek to collaborate with leading scientists around the world to build a critical mass around this multidisciplinary research. Global collaboration is essential to achieving our vision to bring forward novel drugs and vaccines to the community.
Partnerships and business development
We aim to work in partnership with businesses that are keen to take a proactive role in internationally significant public health issues leading to healthier, longer and better lives for Australians.
Study with us
We offer students who want to make a difference and help us make our next discovery various projects, work experience and scholarship opportunities.
There are also postgraduate studies opportunities in glycomics.
March 27, 2017
Griffith ramps up world-first malaria vaccine campaign
Griffith University’s fight towards a cure for one of the world’s most deadly diseases is edging closer after human clinical trials of a malaria vaccine developed by the Institute for Glycomics were a success. Researchers have shown the world-first whole blood-stage malaria parasite vaccine PlasProtecT®, tested in collaboration with the Gold Coast University Hospital, is […]
March 14, 2017
Gold Coast a new Australian hub for clinical trials
From Phase 1 human trials for a Malaria vaccine, to studies aimed at treating osteoporosis and a number of trials into innovative life-saving stroke treatment, the Gold Coast Health & Knowledge Precinct is fast gaining a reputation as a leading location for clinical trials.
December 22, 2016
Griffith University’s research success in 2016
Griffith University has developed the first needle-free vaccine for Strep A with the potential to help millions from suffering, uncovered the history of Aboriginal Australians in a world first genomic study and celebrated a scientist being named 2017 Queensland Australian of the Year – all in one short year.